SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001437749-21-022254
Filing Date
2021-09-16
Accepted
2021-09-16 14:42:59
Documents
13
Period of Report
2021-09-13
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A vxrt20210916_8ka.htm   iXBRL 8-K/A 24708
  Complete submission text file 0001437749-21-022254.txt   163623

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20210913.xsd EX-101.SCH 3593
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20210913_def.xml EX-101.DEF 12175
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20210913_lab.xml EX-101.LAB 16369
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20210913_pre.xml EX-101.PRE 12445
6 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20210916_8ka_htm.xml XML 2782
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-35285 | Film No.: 211257728
SIC: 2836 Biological Products, (No Diagnostic Substances)